Genomic Valley Biotech Limited is an India-based company, which is engaged in the business of consultancy, and trading in agricultural and horticultural products. The Company is providing consultancy on high-tech cultivation through environment-controlled poly houses, NFT & DFT and others, and organic farming - open field cultivation using bio-fertilizer. It is involved in commercial greenhouse cultivation of crops like seed less cucumber, capsicum and others. It is involved in commercial floriculture activities with flowers like Gerbera, Chrysanthemum and others. It extends turnkey support to farmers and entrepreneurs in setting up of greenhouses and polyhouses. It is acting as authorized dealer of Netafim Irrigations India Pvt Ltd, an Israeli company specialized in marketing and selling of its irrigation related products. It is involved in the manufacturing and marketing of bio-fertilizer commercially to promote organic farming. It has a commercial plant tissue culture laboratory.
GENOMIC VALLEY BIOTECH LIMITED Financial Highlights
- Revenue: GENOMIC VALLEY BIOTECH LIMITED reported revenue of ₹0.27 crore in FY26 vs ₹0.84 crore in FY25. It showed a decrease of 67.86% on a yearly basis.
- Operating Profit: GENOMIC VALLEY BIOTECH LIMITED reported an operating profit of ₹0.04 crore in FY26 vs ₹0.44 crore in FY25. It showed a decrease of 90.91% on a year-on-year basis.
- Net Profit: GENOMIC VALLEY BIOTECH LIMITED reported a net profit of ₹0.03 crore in FY26 vs ₹0.36 crore in FY25. It showed a decrease of 91.67% on a yearly basis.
GENOMIC VALLEY BIOTECH LIMITED Quarterly Result Highlights
- GENOMIC VALLEY BIOTECH LIMITED reported revenue of ₹0.04 crore in Mar 2026, compared with ₹0.05 crore in Dec 2025, representing a decrease of 20.00% on a quarter-on-quarter (QoQ) basis.
- GENOMIC VALLEY BIOTECH LIMITED reported an operating profit of ₹0.00 crore in Mar 2026, compared with ₹0.01 crore in Dec 2025, representing a decrease of 100.00% on a quarter-on-quarter (QoQ) basis.
- GENOMIC VALLEY BIOTECH LIMITED reported a loss of ₹0.01 crore in Mar 2026, compared with ₹0.01 crore in Dec 2025, reflecting a decrease of 200.00% on a QoQ basis.
- The earnings per share (EPS) of GENOMIC VALLEY BIOTECH LIMITED stood at ₹1.17 during Mar 2026.